ESSA Pharma Performance
| EPIXDelisted Stock | USD 0.20 0.00 0.00% |
The firm shows a Beta (market volatility) of 5.69, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ESSA Pharma will likely underperform. At this point, ESSA Pharma has a negative expected return of -0.9%. Please make sure to confirm ESSA Pharma's jensen alpha and accumulation distribution , to decide if ESSA Pharma performance from the past will be repeated at future time.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days ESSA Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in February 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 33.7 M | |
| Total Cashflows From Investing Activities | 91.8 M |
ESSA |
ESSA Pharma Relative Risk vs. Return Landscape
If you would invest 21.00 in ESSA Pharma on October 3, 2025 and sell it today you would lose (1.00) from holding ESSA Pharma or give up 4.76% of portfolio value over 90 days. ESSA Pharma is currently does not generate positive expected returns and assumes 4.07% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than ESSA, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ESSA Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ESSA Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ESSA Pharma, and traders can use it to determine the average amount a ESSA Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2223
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EPIX |
Based on monthly moving average ESSA Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ESSA Pharma by adding ESSA Pharma to a well-diversified portfolio.
ESSA Pharma Fundamentals Growth
ESSA Stock prices reflect investors' perceptions of the future prospects and financial health of ESSA Pharma, and ESSA Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ESSA Stock performance.
| Return On Equity | -0.21 | |||
| Return On Asset | -0.15 | |||
| Current Valuation | (99.33 M) | |||
| Shares Outstanding | 47.31 M | |||
| Price To Earning | (1.12) X | |||
| Price To Book | 0.09 X | |||
| EBITDA | (28.45 M) | |||
| Cash And Equivalents | 174.6 M | |||
| Cash Per Share | 3.96 X | |||
| Total Debt | 329.26 K | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 2.45 X | |||
| Cash Flow From Operations | (22.72 M) | |||
| Earnings Per Share | (0.57) X | |||
| Total Asset | 128.11 M | |||
| Retained Earnings | (208 M) | |||
| Current Asset | 10.02 M | |||
| Current Liabilities | 3.63 M | |||
About ESSA Pharma Performance
Evaluating ESSA Pharma's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if ESSA Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ESSA Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada. Essa Pharma is traded on NASDAQ Exchange in the United States.Things to note about ESSA Pharma performance evaluation
Checking the ongoing alerts about ESSA Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ESSA Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ESSA Pharma is not yet fully synchronised with the market data | |
| ESSA Pharma generated a negative expected return over the last 90 days | |
| ESSA Pharma has some characteristics of a very speculative penny stock | |
| ESSA Pharma has high historical volatility and very poor performance | |
| ESSA Pharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (28.54 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ESSA Pharma currently holds about 174.6 M in cash with (22.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 74.0% of the company shares are held by institutions such as insurance companies |
- Analyzing ESSA Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ESSA Pharma's stock is overvalued or undervalued compared to its peers.
- Examining ESSA Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ESSA Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ESSA Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ESSA Pharma's stock. These opinions can provide insight into ESSA Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in ESSA Stock
If you are still planning to invest in ESSA Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ESSA Pharma's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |